---
title: "Estimating Direct Impact of Influenza Vaccination with an Extended Static Compartmental Model"
id: "medrxiv-17-estimating-the-direct-impact-of-influenza-vaccination-and-vaccine-averted"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-17-estimating-the-direct-impact-of-influenza-vaccination-and-vaccine-averted"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.23.26366241v1?rss=1"
published_at: "2026-10-26T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Estimating Direct Impact of Influenza Vaccination with an Extended Static Compartmental Model
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-17-estimating-the-direct-impact-of-influenza-vaccination-and-vaccine-averted
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.23.26366241v1?rss=1)
- **Published At:** 2026-10-26T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The authors extended a previously developed **static compartment model** to estimate direct impact of **influenza vaccination** across multiple seasons. - Model extensions incorporated multi-season dynamics, waning of natural and vaccine-induced immunity, and separate **vaccine effectiveness** (VE) for hospitalized versus non-hospitalized illness. - The demonstration datasets included a synthetic Northern Hemisphere–like seasonality and a hypothetical year-round activity pattern spanning four seasons among adults >65 years. - Assumed VE values used in the demonstration: 37% (17%–53%) against symptomatic illness and 45% (28%–59%) against hospitalization; these values were reported by the authors. - Under a Northern Hemisphere–like scenario with mean annual vaccine coverage of 33%, the model estimated vaccination averted 15.1% (95% UI: 12.2%–16.3%) of influenza-associated illnesses across four seasons. - The corresponding annual prevented fraction for hospitalized deaths in that scenario ranged roughly 14.4% to 18.5% across seasons (95% UIs reported). - Under a hypothetical year-round vaccination program with 20% annual coverage, vaccination averted 4.9% (95% UI: 3.8%–5.4%) of illnesses across four seasons. - Annual prevented fractions for hospitalized deaths under the year-round scenario were reported in the 5.5%–5.8% range (95% UIs provided). - The model and its implementation are publicly available via the authors’ GitHub repository (link provided in the source). - The manuscript is a medRxiv preprint and has not been peer reviewed; the source did not report detailed parameter values for waning immunity, nor full calibration or validation metrics in the abstract.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=l0ekiWvAgmcc7IlaIlRHmrY2_Eu2IZp_NHwT8oWrFJk-1793111335.7742307-1.2.1.1-NlxWjnp6K2WrWXoszKZyP.8bPc2rgLQLEPEysUQwjyCYfBPd749sGT2LTQK3hl1G) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.10.23.26366241v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Estimating the Direct Impact of Influenza Vaccination and Vaccine-Averted Illnesses Using an Extended Static Compartmental Model [ View ORCID Profile](http://orcid.org/0000-0002-0845-2293)Young Moo Yoo, Anna N Chard, Jorge H Jara, [ View ORCID Profile](http://orcid.org/0000-0002-0483-9941)Melissa A Rolfes, Paula Couto, Francisco Nogareda, Lindsey M Duca, Stefano Tempia doi: https://doi.org/10.64898/2026.10.23.26366241 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Young Moo Yoo 1 US Centers for Disease Control and Prevention; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Young%2BMoo%2BYoo%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Yoo%20YM&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AYoung%2BMoo%2BYoo%2B) * [ORCID record for Young Moo Yoo](http://orcid.org/0000-0002-0845-2293 "Open in new tab") * For correspondence: opp8@cdc.gov Anna N Chard 1 US Centers for Disease Control and Prevention; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Anna%2BN%2BChard%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Chard%20AN&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AAnna%2BN%2BChard%2B) Jorge H Jara 2 Pan American Health Organization; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jorge%2BH%2BJara%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Jara%20JH&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AJorge%2BH%2BJara%2B) Melissa A Rolfes 3 Centers for Disease Control and Prevention; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Melissa%2BA%2BRolfes%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Rolfes%20MA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMelissa%2BA%2BRolfes%2B) * [ORCID record for Melissa A Rolfes](http://orcid.org/0000-0002-0483-9941 "Open in new tab") Paula Couto 2 Pan American Health Organization; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Paula%2BCouto%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Couto%20P&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3APaula%2BCouto%2B) Francisco Nogareda 2 Pan American Health Organization; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Francisco%2BNogareda%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Nogareda%20F&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AFrancisco%2BNogareda%2B) Lindsey M Duca 1 US Centers for Disease Control and Prevention; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Lindsey%2BM%2BDuca%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Duca%20LM&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ALindsey%2BM%2BDuca%2B) Stefano Tempia 4 Task Force for Global Health * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Stefano%2BTempia%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Tempia%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AStefano%2BTempia%2B) * [Abstract](https://www.medrxiv.org/content/10.64898/2026.10.23.26366241v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1330970/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.10.23.26366241v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1330970/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.10.23.26366241v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1330970/1) * [Supplementary material](https://www.medrxiv.org/content/10.64898/2026.10.23.26366241v1.supplementary-material)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_data/node:1330970/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.10.23.26366241v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1330970/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.10.23.26366241v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1330970/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract A previously developed static compartment model informed influenza program decisions by estimating the direct impact of influenza vaccination. To improve the estimation of the burden averted by vaccination, we extended this model to consider multiple influenza seasons, allow natural and vaccine-induced immunity to wane over time allow influenza vaccine effectiveness (VE) to differ by hospitalized versus non-hospitalized influenza-associated illness, and measure deaths averted. For model demonstration, we created a synthetic Northern Hemisphere-like and year-round influenza activity dataset spanning four seasons among older adults (>65 years) and assumed VE against symptomatic illness of 37% (17%-53%) and VE against hospitalization of 45% (28%-59%). Under Northern Hemisphere-like activity and an existing vaccination program with an average annual vaccine coverage of 33%, vaccination averted 15.1% (95% UI: 12.2%-16.3%) of influenza-associated illnesses across four seasons; the annual prevented fraction for hospitalized deaths ranged from 14.4% (95% UI: 11.7%-16.8%) to 18.5% (95% UI: 14.9%-21.5%). Under a hypothetical year-round vaccination program with an annual coverage of 20%, vaccination averted 4.9% (95% UI: 3.8%-5.4%) of influenza-associated illnesses across four seasons; the annual prevented fraction for hospitalized deaths ranged from 5.5% (95% UI: 4.3%-6.5%) and 5.8% (95% UI: 4.8%-6.6%). These model extensions allow estimation of vaccine-averted burden across multiple seasons and diverse vaccination program settings, providing information to support influenza vaccination decision-making. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability The model described in this manuscript is implemented in a publicly available tool at Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license. bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.10.23.26366241v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.10.22.26366029v1 "Proteogenomics captures a midlife biological state of Alzheimer's disease susceptibility")[Next ](https://www.medrxiv.org/content/10.64898/2026.10.22.26366247v1 "Smartphone-based Non-Invasive Classification of Anemia Severity using Deep Learning: A Cross-Sectional Study in Rural India") Posted October 26, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.10.23.26366241v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/10/26/2026.10.23.26366241.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.10.23.26366241v1#p-5) [Supplementary Material ](https://www.medrxiv.org/content/10.64898/2026.10.23.26366241v1.supplementary-material) [ Data/Code](https://www.medrxiv.org/content/early/2026/10/26/2026.10.23.26366241.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Estimating the Direct Impact of Influenza Vaccination and Vaccine-Averted Illnesses Using an Extended Static Compartmental Model Young Moo Yoo, Anna N Chard, Jorge H Jara, Melissa A Rolfes, Paula Couto, Francisco Nogareda, Lindsey M Duca, Stefano Tempia medRxiv 2026.10.23.26366241; doi: https://doi.org/10.64898/2026.10.23.26366241 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.23.26366241v1%26text%3DEstimating%2520the%2520Direct%2520Impact%2520of%2520Influenza%2520Vaccination%2520and%2520Vaccine-Averted%2520Illnesses%2520Using%2520an%2520Extended%2520Static%2520Compartmental%2520Model "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.23.26366241v1%26t%3DEstimating%2520the%2520Direct%2520Impact%2520of%2520Influenza%2520Vaccination%2520and%2520Vaccine-Averted%2520Illnesses%2520Using%2520an%2520Extended%2520Static%2520Compartmental%2520Model "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.23.26366241v1%26title%3DEstimating%2520the%2520Direct%2520Impact%2520of%2520Influenza%2520Vaccination%2520and%2520Vaccine-Averted%2520Illnesses%2520Using%2520an%2520Extended%2520Static%2520Compartmental%2520Model%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.10.23.26366241v1%26title%3DEstimating%2520the%2520Direct%2520Impact%2520of%2520Influenza%2520Vaccination%2520and%2520Vaccine-Averted%2520Illnesses%2520Using%2520an%2520Extended%2520Static%2520Compartmental%2520Model "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.10.23.26366241) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.10.23.26366241v1&count=horizontal&via=&text=Estimating%20the%20Direct%20Impact%20of%20Influenza%20Vaccination%20and%20Vaccine-Averted%20Illnesses%20Using%20an%20Extended%20Static%20Compartmental%20Model&counturl=www.medrxiv.org/content/10.64898/2026.10.23.26366241v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (637) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (914) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (348) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4955) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (492) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (425) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (674) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1677) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16181) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (36) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1236) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7227) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (747) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1092) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5238) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1457) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1817) * [Hematology](https://www.medrxiv.org/collection/hematology) (598) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1373) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16446) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1196) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (692) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (156) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (742) * [Neurology](https://www.medrxiv.org/collection/neurology) (7523) * [Nursing](https://www.medrxiv.org/collection/nursing) (375) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1115) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1290) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1035) * [Oncology](https://www.medrxiv.org/collection/oncology) (3717) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1082) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (403) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (463) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (498) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (143) * [Pathology](https://www.medrxiv.org/collection/pathology) (718) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1849) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (749) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (781) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (6079) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9932) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2506) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1501) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1263) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (657) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (796) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (595) * [Surgery](https://www.medrxiv.org/collection/surgery) (796) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (109) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (316) * [Urology](https://www.medrxiv.org/collection/urology) (304) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comment
## Related Clinical Research

- [Washington resident dies after exposure to H5N1-infected dairy cattle](https://medichelpline.com/clinical-feed/stat-news-0-washington-state-resident-dies-from-bird-flu-following-exposure-to-infected.md)
- [Helen Branswell, veteran infectious disease reporter at STAT, dies at 69](https://medichelpline.com/clinical-feed/stat-news-0-helen-branswell-whose-reporting-on-infectious-diseases-and-public-health-drew.md)
- [Increased risk of acute gastroenteritis after COVID-19 hospitalisation: a retrospective England an](https://medichelpline.com/clinical-feed/medrxiv-3-risk-of-acute-gastroenteritis-following-covid-19-exposure-a-retrospective.md)
- [FDA approves Moderna’s mRNA flu vaccine mFLUSIVA for adults 50+: what clinicians should know](https://medichelpline.com/clinical-feed/medical-news-today-0-moderna-s-mrna-flu-vaccine-approved-by-fda-when-is-it-available.md)
- [MMR vaccines: separating measles, mumps, rubella shots — myths and facts](https://medichelpline.com/clinical-feed/medical-news-today-0-should-the-measles-mumps-rubella-vaccines-be-separate-myths-vs-facts.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.